2m 2m 2m 2m 2m 2m 2m
Pacific Bio CA (PACB)
NASDAQ
$2.09-$0.15 (-6.70%)
Price as of Nov 11, 2026 7:41 PM EST- $696.3MMarket Cap
- 20.43%1-Year Change
- Medical DevicesIndustry
Pacific Bio CA (PACB)
$2.09-$0.15 (-6.70%)
PACB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.24 | ||
Change | -$0.12 (-5.08%) | ||
Open | $2.31 | ||
High | $2.35 | ||
Low | $2.12 | ||
Previous Close | $2.36 | ||
Volume | 8,835,076 | ||
30-Day Average Volume | 12,611,478 | ||
1-Week Change | -8.20% | ||
1-Month Change | -3.86% | ||
1-Year Change | 20.43% | ||
3-Year Change | -65.64% | ||
5-Year Change | -91.54% | ||
Fundamentals | |||
Shares Outstanding | 310.8M | ||
Total Assets | $721.1M | ||
Market Cap | $696.3M | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $34.0M | ||
Net Income | -$37.8M | ||
Free Cash Flow | -$38.6M | ||
EBIT | -$35.8M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $241.3M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | 38 | ||
P/B | -11 | ||
P/E | -19 | ||
PEG | -1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue